Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1981-8-20
|
pubmed:abstractText |
Six cases of subconjunctival tumor clinically compatible with the appearance of subconjunctival lymphoma were evaluated. Two of the patients, Cases 1 and 2, were under treatment with either prednisone or gold therapy for severe rheumatoid arthritis. Patient 3 manifested further evidence of systemic disease (auxillary lymph node). Of the remaining cases, patient 4 had no further evidence of systemic involvement, whereas patient 5 was suspected of having a gastrointestinal tumor. The last case, a patient known to have pulmonary lymphoma, presented with dry eye and multiple subconjunctival lymphomatous masses. Immune surface marker studies demonstrated a B-cell monoclonal subconjunctival lymphoma, suggestive of an improved survival when compared to null cell-type lesions. Immune surface marker studies offer a new commercially available method for classifying and prognosticating subconjunctival lymphomas.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0003-4886
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
471-5
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7247193-Aged,
pubmed-meshheading:7247193-Antineoplastic Agents,
pubmed-meshheading:7247193-Conjunctival Neoplasms,
pubmed-meshheading:7247193-Female,
pubmed-meshheading:7247193-Humans,
pubmed-meshheading:7247193-Lymphoma,
pubmed-meshheading:7247193-Male,
pubmed-meshheading:7247193-Middle Aged,
pubmed-meshheading:7247193-Receptors, Antigen, B-Cell
|
pubmed:year |
1981
|
pubmed:articleTitle |
Subconjunctival lymphoma: a review of six suspected cases and the use of immunologic surface markers.
|
pubmed:publicationType |
Journal Article,
Case Reports
|